journal article·2020-01-01Open access

LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis

Junwen Ma, Lihai Zhang, Anquan Shang, Hu Song, Jiege Huo, Mingjian Zhang, Liuqin Jiang

Abstract

Long non-coding RNAs and microRNAs are functional regulators in tumour progression. Herein, we revealed the level LINC02163 was up-regulated in CRC tissues and cell lines, and the expression of LINC02163 negatively correlated with prognosis of CRC patients. Functional experiments demonstrated knockdown of LINC02163 significantly attenuated CRC cells proliferation and metastasis. Mechanism analysis showed miR-511-3p could bind LINC02163 and AKT3, and the expressional level of miR-511-3p negatively correlated with the abundance of LINC02163 and AKT3. Inhibition of LINC02163 suppressed cell proliferation, while transfection of miR-511-3p inhibitor or AKT3 in LINC02163-depletion cells restored cell growth and abolished the cell cycle arrest in G0/G1 phase. Therefore, it was indicated that LINC02163 exerted pro-tumour effect through miR-511-3p/AKT3 axis and was prognostic marker for colorectal cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · Circular RNAs in diseases · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastrointestinal Surgery, The General Hospital of Ningxia Medical University

Department of General Surgery and Pediatrics, The First Affiliated Hospital of Jiamusi University

Department of Laboratory Medicine, The Sixth People’s Hospital of Yancheng City

Department of Gastrointestinal Surgery, The Affiliated Hospital of Xuzhou Medical University

Department of Oncology, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine

Center of Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University

References (26)

Show source-provided references
1. 10.20892/j.issn.2095-3941.2015.010310.20892/j.issn.2095-3941.2015.0103 ↗
2. 10.1038/ajg.2017.21210.1038/ajg.2017.212 ↗
3. 10.1038/onc.2013.24410.1038/onc.2013.244 ↗
4. 10.1186/s12885-018-4701-210.1186/s12885-018-4701-2 ↗
5. 10.3748/wjg.v20.i22.678610.3748/wjg.v20.i22.6786 ↗
6. 10.1038/nrd.2017.5910.1038/nrd.2017.59 ↗
7. 10.1101/gr.082701.10810.1101/gr.082701.108 ↗
8. 10.7150/thno.811310.7150/thno.8113 ↗
9. 10.3892/mmr.2017.755210.3892/mmr.2017.7552 ↗
10. 10.3727/096504017X1503155792413210.3727/096504017X15031557924132 ↗
11. 10.1186/s12943-019-0957-710.1186/s12943-019-0957-7 ↗
12. 10.1038/s41419-018-0759-710.1038/s41419-018-0759-7 ↗
13. Dong YZ, Meng XM, Li GS. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 2018;22:2671–2679.
14. 10.1016/j.cell.2007.05.02210.1016/j.cell.2007.05.022 ↗
15. 10.2217/fon.12.5210.2217/fon.12.52 ↗
16. 10.1002/jcp.2638310.1002/jcp.26383 ↗
17. 10.7150/jca.2102410.7150/jca.21024 ↗
18. 10.1080/21691401.2018.146446210.1080/21691401.2018.1464462 ↗
19. 10.1158/1055-9965.EPI-16-000610.1158/1055-9965.EPI-16-0006 ↗
20. 10.18632/oncotarget.1222010.18632/oncotarget.12220 ↗
21. 10.3390/ijms1403465510.3390/ijms14034655 ↗
22. 10.1007/978-981-10-1498-7_810.1007/978-981-10-1498-7_8 ↗
23. 10.18632/oncotarget.2159010.18632/oncotarget.21590 ↗
24. 10.1016/j.biochi.2017.06.00710.1016/j.biochi.2017.06.007 ↗
25. 10.1074/jbc.274.31.2152810.1074/jbc.274.31.21528 ↗
26. 10.1016/j.cellsig.2013.03.02510.1016/j.cellsig.2013.03.025 ↗